JF
APTO

Jump Financial’s Aptose Biosciences, Inc. APTO Stock Holding History

Jump Financial’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-234
Closed -$229K – 1830
2021
Q3 		$229K Buy
234
+24
+11% +$30K 0.02% 807
2021
Q2 		$314K Buy
+210
New +$457K 0.03% 657

Other funds holding APTO

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SMH
Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Jump Financial's APTO Position: Q4 2021 in Review

Jump Financial sold out of Aptose Biosciences, Inc. (APTO) in Q4 2021, closing a stake of 234 shares — an estimated $229K sold.

Jump Financial first reported a position in APTO in Q2 2021 and held it in 2 quarters. The position peaked at $314K in Q2 2021. 58 funds tracked by Wall St. Rank hold APTO as of Q4 2021.

  • Jump Financial reported no remaining Aptose Biosciences, Inc. position as of Q4 2021 after selling out during the quarter.
  • Jump Financial sold 234 Aptose Biosciences, Inc. shares in Q4 2021, an estimated $229K.
  • Jump Financial first reported a position in Aptose Biosciences, Inc. in Q2 2021 and held it in 2 quarters.
  • Jump Financial's Aptose Biosciences, Inc. position peaked at $314K in Q2 2021.
  • 58 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q4 2021.

Based on Jump Financial's 13F filing for Q4 2021, filed 10 Feb 2022.